Related Experiment Video
Updated: Jun 2, 2026

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina
Published on: June 23, 2014
Retinoid-induced expression and activity of an immediate early tumor suppressor gene in vascular smooth muscle cells
Jeffrey W Streb1, Xiaochun Long, Ting-Hein Lee
1Aab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America.
Abstract:
Retinoids are used clinically to treat a number of hyper-proliferative disorders and have been shown in experimental animals to attenuate vascular occlusive diseases, presumably through nuclear receptors bound to retinoic acid response elements (RARE) located in target genes. Here, we show that natural or synthetic retinoids rapidly induce mRNA and protein expression of a specific isoform of A-Kinase Anchoring Protein 12 (AKAP12β) in cultured smooth muscle cells (SMC) as well as the intact vessel wall. Expression kinetics and actinomycin D studies indicate Akap12β is a retinoid-induced, immediate-early gene. Akap12β promoter analyses reveal a conserved RARE mildly induced with atRA in a region that exhibits hyper-acetylation. Immunofluorescence microscopy and protein kinase A (PKA) regulatory subunit overlay assays in SMC suggest a physical association between AKAP12β and PKA following retinoid treatment. Consistent with its designation as a tumor suppressor, inducible expression of AKAP12β attenuates SMC growth in vitro. Further, immunohistochemistry studies establish marked decreases in AKAP12 expression in experimentally-injured vessels of mice as well as atheromatous lesions in humans. Collectively, these results demonstrate a novel role for retinoids in the induction of an AKAP tumor suppressor that blocks vascular SMC growth thus providing new molecular insight into how retiniods may exert their anti-proliferative effects in the injured vessel wall.
Insights
Retinoids rapidly increase A-Kinase Anchoring Protein 12 beta (AKAP12β) expression, a tumor suppressor that inhibits vascular smooth muscle cell growth. This reveals a new mechanism for retinoid action in preventing vascular diseases.
Area of Science:
- Molecular Biology
- Cell Biology
- Vascular Biology
Background:
- Retinoids are clinically used for hyper-proliferative disorders.
- Retinoids experimentally attenuate vascular occlusive diseases.
- Retinoid action is mediated through retinoic acid response elements (RAREs).
Purpose of the Study:
- To investigate the molecular mechanisms of retinoid action in vascular smooth muscle cells (SMC).
- To identify novel retinoid-induced genes involved in vascular health.
- To explore the role of AKAP12β in retinoid-mediated anti-proliferative effects.
Main Methods:
- Studied retinoid induction of AKAP12β mRNA and protein in cultured SMC and intact vessel walls.
- Performed expression kinetics and actinomycin D studies to determine gene regulation.
- Analyzed Akap12β promoter for RAREs and used immunofluorescence microscopy and PKA overlay assays.
- Assessed SMC growth in vitro and AKAP12 expression in experimentally-injured mouse vessels and human atheromatous lesions.
Main Results:
- Retinoids rapidly induce AKAP12β mRNA and protein expression in SMC and vessel walls.
- Akap12β is a retinoid-induced, immediate-early gene with a conserved RARE in its promoter.
- AKAP12β physically associates with protein kinase A (PKA) and attenuates SMC growth.
- AKAP12 expression is decreased in injured vessels and human atherosclerotic lesions.
Conclusions:
- Retinoids induce the tumor suppressor AKAP12β, which inhibits vascular SMC proliferation.
- This identifies a novel retinoid-induced pathway targeting vascular SMC growth.
- Provides molecular insight into retinoid's anti-proliferative effects in the injured vessel wall.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Regulation of Angiogenesis and Blood Supply
TGF - β Signaling Pathway

